These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunolocalization of tenascin-C in vitiligo. Abdou AG; Maraee AH; Shoeib MA; Elbana R Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383 [TBL] [Abstract][Full Text] [Related]
6. Membrane lipid alterations as a possible basis for melanocyte degeneration in vitiligo. Dell'Anna ML; Ottaviani M; Albanesi V; Vidolin AP; Leone G; Ferraro C; Cossarizza A; Rossi L; Picardo M J Invest Dermatol; 2007 May; 127(5):1226-33. PubMed ID: 17235326 [TBL] [Abstract][Full Text] [Related]
7. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors. Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274 [TBL] [Abstract][Full Text] [Related]
9. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Kumar R; Parsad D; Kanwar AJ; Kaul D Br J Dermatol; 2011 Aug; 165(2):285-91. PubMed ID: 21428970 [TBL] [Abstract][Full Text] [Related]
10. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Cario-André M; Pain C; Gauthier Y; Taïeb A Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512 [TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. Schallreuter KU; Moore J; Wood JM; Beazley WD; Gaze DC; Tobin DJ; Marshall HS; Panske A; Panzig E; Hibberts NA J Investig Dermatol Symp Proc; 1999 Sep; 4(1):91-6. PubMed ID: 10537016 [TBL] [Abstract][Full Text] [Related]
12. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153 [TBL] [Abstract][Full Text] [Related]
13. H Xu P; Xue YN; Ji HH; Tan C; Guo S Exp Dermatol; 2020 Aug; 29(8):733-741. PubMed ID: 32580253 [TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate (EGCG) Suppresses the Trafficking of Lymphocytes to Epidermal Melanocytes via Inhibition of JAK2: Its Implication for Vitiligo Treatment. Ning W; Wang S; Dong X; Liu D; Fu L; Jin R; Xu A Biol Pharm Bull; 2015; 38(11):1700-6. PubMed ID: 26345342 [TBL] [Abstract][Full Text] [Related]
15. Melanocytes are not absent in lesional skin of long duration vitiligo. Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216 [TBL] [Abstract][Full Text] [Related]
16. Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas. Nugroho H; Ahmad Fadzil MH; Shamsudin N; Hussein SH Skin Res Technol; 2013 Feb; 19(1):e72-7. PubMed ID: 22233154 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo. van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370 [TBL] [Abstract][Full Text] [Related]
18. Metabo-miR: miR-211 Regulates Mitochondrial Energy Metabolism in Vitiligo. Spiegelman VS; Elcheva IA J Invest Dermatol; 2017 Sep; 137(9):1828-1830. PubMed ID: 28843294 [TBL] [Abstract][Full Text] [Related]
19. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Dell'anna ML; Picardo M Pigment Cell Res; 2006 Oct; 19(5):406-11. PubMed ID: 16965269 [TBL] [Abstract][Full Text] [Related]
20. Epidermal hydrogen peroxide is not increased in lesional and non-lesional skin of vitiligo. Zailaie MZ Arch Dermatol Res; 2017 Jan; 309(1):31-42. PubMed ID: 27783153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]